Ketamine IV for the prevention of depression in the elderly: new data

Published Date: 13 Mar 2023

Intravenous (IV) ketamine is effective in adults resistant to depression. The response was similar to that seen in younger patients, two new studies show.

Read Full News

Latest News

Poisoned Baby Food Part 0f Attempted Extortion

Jars of baby food deliberately tainted with rat poison and found in Austria, the Czech Republic, and Slovakia were part of an attempt to extort their manufacturer.

'Mental Health Episode' Puts AFL Player Welfare in Spotlight

A mental health episode suffered by an Australian Football League player has exposed the limits of the high-quality support structures offered by its clubs.

Longer ED Stay Linked to Early Clinical Deterioration

A longer stay in the emergency department is associated with an increased risk for early clinical deterioration among patients, a study finds.

Shhhh: Quieter Hospitals Offer Benefits to Inpatients

Quiet is better in hospital rooms and corridors. Making it so isn’t simple, but the benefits are clear.

Can a Public-Private Partnership Blunt Hospital Violence?

In partnering with the FBI, the AHA is offering a robust framework to identify and de-escalate workplace threats.

Can a Common, Safe, Low-Cost Med Boost Cognition After TBI?

Gabapentin, a widely available medication, is linked to improved cognitive outcomes and reduced mortality after TBI, results of a large observational study show.

Todays Updates

CAR-T Induces Deep, Durable Remission in Smoldering Myeloma

In a pilot study — the first to test CAR-T therapy in smoldering multiple myeloma — patients with high-risk disease remained MRD-negative for more than 15 months. But is it a cure?

‘Bar Code’ Biopsy From RNA Could Guide Precision Oncology

New research shows how certain orphan noncoding RNA — oncRNA — can be predictable enough to be a ‘bar code’ identifying specific cancers. Liquid biopsy could be next.

Dasatinib Fails to Improve Outcomes in CBF-AML

A phase 3 study investigates the outcomes associated with intensive chemotherapy with or without dasatinib in core-binding factor acute myeloid leukemia.

CD39 Blockade Shows Potential in Early-Stage Lung Cancer

A single-arm study hints at an uptick in pathologic complete responses when a CD39 blocker is added to perioperative durvalumab and chemotherapy for NSCLC.

Measurable Residual Disease Predicts Real-World AML Relapse

A study of a real-world population underscores measurable residual disease thresholds indicative of the risk for relapse in NPM1-mutated AML, suggesting guidance in treatment decisions.

Todays Updates

CAR-T Induces Deep, Durable Remission in Smoldering Myeloma

In a pilot study — the first to test CAR-T therapy in smoldering multiple myeloma — patients with high-risk disease remained MRD-negative for more than 15 months. But is it a cure?

‘Bar Code’ Biopsy From RNA Could Guide Precision Oncology

New research shows how certain orphan noncoding RNA — oncRNA — can be predictable enough to be a ‘bar code’ identifying specific cancers. Liquid biopsy could be next.

Dasatinib Fails to Improve Outcomes in CBF-AML

A phase 3 study investigates the outcomes associated with intensive chemotherapy with or without dasatinib in core-binding factor acute myeloid leukemia.

CD39 Blockade Shows Potential in Early-Stage Lung Cancer

A single-arm study hints at an uptick in pathologic complete responses when a CD39 blocker is added to perioperative durvalumab and chemotherapy for NSCLC.

Measurable Residual Disease Predicts Real-World AML Relapse

A study of a real-world population underscores measurable residual disease thresholds indicative of the risk for relapse in NPM1-mutated AML, suggesting guidance in treatment decisions.

Latest News

Jars of baby food deliberately tainted with rat poison and found in Austria, the Czech Republic, and Slovakia were part of an attempt to extort their manufacturer.

A mental health episode suffered by an Australian Football League player has exposed the limits of the high-quality support structures offered by its clubs.

A longer stay in the emergency department is associated with an increased risk for early clinical deterioration among patients, a study finds.

Quiet is better in hospital rooms and corridors. Making it so isn’t simple, but the benefits are clear.

In partnering with the FBI, the AHA is offering a robust framework to identify and de-escalate workplace threats.

Gabapentin, a widely available medication, is linked to improved cognitive outcomes and reduced mortality after TBI, results of a large observational study show.

News All Time

Scotland Clears New Option for EGFR Lung Cancer

The Scottish Medicines Consortium has approved osimertinib for adults with unresectable stage III EGFR-mutant NSCLC whose disease has not progressed after platinum-based chemoradiation.

Nurse-Led Hospital Care Can Equal Physician Results

A recent review from Cochrane shows strong performance from major nursing grades in hospital care.

Cannabis and Digestive Health: Clinical Risks

Low-dose cannabis may ease nausea in gastroparesis and chemotherapy, but heavy chronic use can cause cannabinoid hyperemesis; advise a cessation trial to confirm causation.

Toward Community-Led Suicide Prevention for Australian Youth

Community-led and school-based strategies may offer a more effective path forward for suicide prevention, experts say.

Predicting Diverticulitis Recurrence With the Help of AI

An algorithm that reads CT reports can spot and categorize complications of diverticulitis and help predict which patients are likely to have a recurrent episode.

A Probiotic Adjunct May Boost H pylori Eradication

Adding a probiotic to concomitant therapy of clarithromycin, amoxicillin, and metronidazole or tinidazole for Helicobacter pylori infection may improve eradication rates.

A&E Legal Gap Leaves Mental Health Patients at Risk

Patients in mental health crisis can leave A&E before assessment due to unclear legal powers. exposing them to harm, investigators warn.

Antarctic Winter: An ER Doctor’s 13-Month Mission

After a year isolated at Concordia, the emergency physician realized her 90-hour weeks were unsustainable; she returned to Rennes, cut clinical hours to 60%, and prioritized well-being.

Pediatric Chest X-Rays for Common Illness Drop With Program

Use of the imaging tests fell from 34.3% of all ED respiratory visits at baseline to 21.1% with a four-part intervention.

Home-Based Hypnotherapy May Benefit Kids With Abdominal Pain

Home-based guided hypnotherapy added to usual care may help children with functional abdominal pain or irritable bowel syndrome achieve earlier relief at 3 and 6 months than usual care alone.

Surgery to Cure Early-stage Lung Cancer Appears Safe Even Over Age 80

(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.)

NICE Gives Green Light to New Low-Grade Glioma Therapy

NICE has backed vorasidenib for NHS use in England, delaying tumour progression after surgery and reducing the psychological burden of a progressive brain tumour.

AHPRA to Add Sexual Misconduct Findings to Public Register

To help patients make informed decisions, AHPRA will retrospectively publish in the public register tribunal decisions relating to sexual misconduct by healthcare providers.

15 Deaths Are Confirmed After Measles Outbreak in Bangladesh

A measles outbreak in Bangladesh has led to 15 confirmed deaths, officials said on ⁠Wednesday, as the government readies to launch an emergency immunisation programme as...

Belgian Court Orders Poland, Romania to Buy $2.2B of COVID Shots

Belgian court orders Poland and Romania to take delivery of $2.2 billion worth of COVID-19 vaccines made by Pfizer and BioNTech in a case brought by the drugmaker 3 years ago.

Kennedy Sidelining Of US Advisory Panel Delays Updates to Cancer Screening Guidelines

The sidelining by U.S. Health Secretary Robert F. Kennedy Jr. of the advisory panel that decides access to free preventive healthcare is delaying updates to screening...

Recommended News For You

A paper strip test might enable the early detection of cancer.

FDA Greenlights First Engineered Cell Therapy for a Solid Tumor

No Solace From Drug Scarcities; Novel Guidelines Regarding Lymphedema; A "Good" Patient Is Forgotten.

Researchers discover cellular 'doorway' exploited by cancer-causing virus

In Sickle Cell Disease, Lovo-Cel is "Life-Changing, Transformative.".

Recent Rise in Early-Onset Solid Tumors Is Associated with Accelerated Aging.

Obesity-related cancer rising among both younger and older adults worldwide, study finds

Recommended Articles For You

Interplay of Brown Hair, Follicular Biology, and Hair Growth Inhibitors in Melanoma Pathogenesis 

Revolutionizing Cancer Treatment: Advances in Immunotherapy and Cell Therapy 

Real-World Evidence and Patient Voices: Redefining Outcomes in Modern Oncology 

Understanding Epoetin and Its Role in Treating Chronic Kidney Disease  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Cancer care crowdfunding increasingly common, but rarely successful

2.

Perioperative Nivolumab Boosts EFS Versus Neoadjuvant-Only Nivolumab in NSCLC

3.

Q&A: Nipple-Sparing Mastectomy After Breast Radiation

4.

Firefighters who eat better can combat cancer.

5.

X-ray and radar technology combined to reduce cancer screening risks

1.

What Is May-Hegglin Anomaly? Understanding this Rare Blood Disorder

2.

Lu-177 Vipivotide in Prostate Cancer: A Breakthrough in Radioligand Therapy

3.

Lymphomatoid Papulosis: What You Need to Know

4.

A New Perspective on Spherocytosis: Uncovering Innovative Treatments

5.

Neoadjuvant Radiotherapy & Endocrine Therapy in ER+ Breast Cancer Treatment

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII

2.

Efficient Management of First line ALK-rearranged NSCLC - Part VIII

3.

Post Progression Approaches After First-line Third-Generaion ALK Inhibitors

4.

Updates on the First Line Management of ALK+ NSCLC

5.

An In-Depth Look At The Signs And Symptoms Of Lymphoma

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot